Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Investor AB’s Interim Management Statement January-March 2022 webcast conference call

A webcast conference call will be held on Thursday, April 21, 2022, at 10:00 CET. President and CEO Johan Forssell and CFO Helena Saxon will present the Interim Management Statement January-March 2022. The webcast conference call will be held in English via www.investorab.com. For phone access: +44 33 33 00 08 04, +1 631 913 1422 or +46 8 5664 2651, with the PIN code 80934650#. The presentation will be published on our website after the event, where you can also view the event on-demand. The Interim Management Statement is expected to be released around 08:15 CET the same day.

BioStock: Annexin receives FDA approval for phase II study

Earlier this week, Annexin Pharmaceuticals announced that they had received green light from FDA to begin a phase II clinical trial within RVO – a step that the company describes as the most important in its history. The FDA’s decision, which provides a quality seal for the company’s project, also means a shorter path to the application for phase II within additional indications.Read the full article about Annexin Pharmaceuticals at biostock.se: https://www.biostock.se/en/2022/04/annexin-receives-fda-approval-for-phase-ii-study/ This is a press release from BioStock - Connecting

Alfa Laval will release first-quarter earnings on April 26[th] at 13:00 pm CET. The telephone conference will start at 14:00 pm CET

To join the telephone conference – hosted by Alfa Laval’s President and CEO Tom Erixon and CFO Jan Allde – sign up in advance via the link below. Once registered, you will receive a phone number, a participant pin, and a conference pin. Please dial in 10 minutes prior to the scheduled start of the event. http://emea.directeventreg.com/registration/8959035  

Go-live: Zalaris continues to develop Gassco’s HR system with the implementation of SAP SuccessFactors Employee Central

Zalaris, the provider of payroll and HR solutions that simplify work life and support creating sustainable businesses, today announced the successful go-live of Employee Central, an SAP SuccessFactors solution, fully integrated with Zalaris PeopleHub for Gassco.Gassco 's task is to bring natural gas from the Norwegian continental shelf to customers on behalf of natural gas producers and users of the gas transport system. Gassco AS is responsible for transporting all gas from the Norwegian shelf to Europe. The gas transport system is integrated and consists of

Invitation to the Annual General Meeting of AAK AB (publ.)

The shareholders of AAK AB (publ.) are hereby invited to attend the Annual General Meeting to be held on Wednesday, May 18, 2022 at 2:00 p.m. at the premises of Malmö Arena, Hyllie Stationstorg 2 in Malmö, Sweden. The registration for the Annual General Meeting starts at 1:00 p.m. Practical information regarding the Annual General Meeting Notice of the Annual General Meeting is published in a press release, in Post- och Inrikes Tidningar (“the Swedish Official Gazette”) and at www.aak.com. In addition, an advertisement is placed in Svenska Dagbladet. For environmental reasons, please

Save the Date: Clas Ohlson arranges Capital Markets Day on 8 June, 2022

Clas Ohlson invites investors, financial analysts and the media to the company's Capital Markets Day, which will be held on 8 June, 2022, at 10.00-12.00 a.m. CET in the store on Sveavägen 52 in Stockholm. On the same day at 9.00 a.m. CET a presentation of the year-end report for 2021/22 will be held, which participants are also welcome to attend.The Capital Markets Day will be held as a physical event and will also be broadcasted live online for those who prefer to participate digitally. The Capital Markets Day will include an update regarding Clas Ohlson's strategy and priorities, with

CTEK publishes Annual and Sustainability Report for 2021

CTEK has today published Annual and Sustainability report for 2021 at its website. The report is available at https://ctekgroup.com/en/reports-presentation/. The Swedish version of the Annual Report is also available in European Single Electronic Format (ESEF). CTEK has chosen not to print or distribute a hard copy of its Annual Report. Those who are unable to access the report digitally can request a print-out of the by contacting marcus.korsgren@ctek.com. This is information that CTEK AB (publ) is obliged to make public pursuant to the Securities Markets Act (2007:528). The

Notice of Extraordinary General Meeting in Moberg Pharma AB (publ)

Shareholders in Moberg Pharma AB (publ), reg. no. 556697-7426 (the “Company”), are hereby convened to the Extraordinary General Meeting on 3 May 2022.Due to the coronavirus and in an effort to reduce the spread, the Board of Directors has resolved that the Extraordinary General Meeting will be held without the physical presence of shareholders, representatives and third parties, and that the shareholders will only be able to exercise their voting rights through postal voting in accordance with the instructions specified below. Information regarding the resolutions passed by the

Resolutions of Annual General Meeting and Board of Directors of Componenta Corporation

Componenta Corporation, Stock Exchange Release, 8 April 2022 at 10.45 a.m. EEST Componenta Corporation’s Annual General Meeting was held today, 8 April 2022, in Vantaa. In order to limit the spread of the COVID-19 pandemic, the Annual General Meeting was held without the presence at the meeting venue. It was possible for shareholders and their proxy representatives to participate in the meeting and exercise their shareholder rights only by voting in advance and by submitting counterproposals and questions in advance. The AGM supported all the proposals presented to the meeting and

NOTIFICATION OF MANAGERS’ AND CLOSELY RELATED PARTIES’ TRANSACTIONS WITH DAMPSKIBSSELSKABET NORDEN A/S’ SHARES IN CONNECTION WITH SHARE BUY-BACK PROGRAM

ANNOUNCEMENT NO. 92 - 8 APRIL 2022 In connection with the announced share buy-back program in Dampskibsselskabet NORDEN A/S, A/S Motortramp participates by selling shares pro rata in order to maintain the current ownership of just under 32% of the shares in Dampskibsselskabet NORDEN A/S. The market will be informed accordingly – see the attached file and announcement no. 56/2022. Kind regards, Dampskibsselskabet NORDEN A/S Martin Badsted CFO For further information:Thomas France, Investor Communications Partner, tel.: 3315 0451

Capital increase in TORM due to exercise of Restricted Share Units as part of TORM’s incentive program

TORM plc (“TORM”) increases its share capital by 17,512 A-shares (corresponding to a nominal value of USD 175.12) as a result of the exercise of a corresponding number of Restricted Share Units.   The capital increase is carried out without any pre-emption rights for existing shareholders or others. 10,423 of the new shares have been subscribed for in cash at DKK 43.4 per A-share, the remaining 7,089 of the new shares have been subscribed for in cash at DKK 53.5 per A-share. All with a nominal value of USD 0.01 each.   The new shares are ordinary shares without any special

IAR Systems brings low-code state machine design solution to Linux

Latest version of the state machine design solution IAR Visual State adds cross-platform support for both Windows and Linux, and enables automated generation of C, C++, C# or Java codeUppsala, Sweden—April 8, 2022—IAR Systems®, the world leader of software and services for embedded development, today announced the latest version of the graphical modeling and code generation solution IAR Visual State. The new version introduces cross-platform host support that allows IAR Visual State to run on either Linux or Windows, enabling flexible and efficient development workflows based on state

Eevia Health appoints new distributor

Eevia Health Plc, (”Eevia” or ”The Company”) has appointed Select Ingredients, San Diego, California, USA, as new distributor in the territory of the USA.Eevia Health has appointed Select Ingredients Inc as distributor in the USA. Select Ingredients will focus on organic ingredients for food and supplements applications. The parties will also undertake a joint cooperation on the development and marketing of a new innovative polyphenol extract, which will be sold as a branded ingredient to selected customers. “Select Ingredients is a results-oriented distributor with a strong track record

BioStock: Sprint Biosciences CSO comments on further VADA validation

After last year’s out-licensing of Vps34, the focus is now on the next program in Sprint Bioscience’s portfolio. The VADA program has come the furthest and new research findings provide further validation to the target protein VRK1. In addition to a better understanding of the role the protein plays in cancer, the results also point to a broadened commercial potential for VADA. BioStock contacted Sprint Bioscience’s Head of Research Martin Andersson to find out more.Read the full article at biostock.se:https://www.biostock.se/en/2022/04/sprint-biosciences-cso-comments-on-further-vada-

Toivo Group Plc to carry out a unique 39-apartment and approximately EUR 7.6 million housing project Tuusulan Olympiakasarmi

Press release, 8 April 2022 at 10:00 a.m. Toivo Group Plc (“the Company” or “Toivo”) has acquired a property in Hyrylä, Tuusula, and will start converting the former barracks into apartments during summer 2022. In the project, Toivo will build loft-style rental apartments, due for completion in spring 2023. The apartments will be heated with district heating. Tens of thousands of conscripts have completed their national service at the old garrison area in Hyrylä, Tuusula. In Toivo’s project, one of the barracks buildings will be converted into unique rental apartments. The barracks

Redwood Pharma to attend ARVO (Denver), the most important global conference in ophthalmology

The Association of Researchers in Vision and Ophthalmology will hold their annual meeting in Denver, Colorado (USA) between May 1-4, 2022. ARVO is the world’s leading conference in ophthalmology where researchers from academia and industry can meet to share the latest developments in science and therapeutic development.   Redwood Pharma looks to share developments regarding its RP501 and RP101 therapies for treatment of dry eye disease with potential clinical and commercial partners.   To schedule a meeting please contact:   Martin Vidaeus, CEO Martin.vidaeus@

BillerudKorsnäs’ Annual and Sustainability Report 2021

BillerudKorsnäs publishes its Annual and Sustainability report for 2021. BillerudKorsnäs’ Annual and Sustainability report for 2021 is from today available on the company’s website, www.billerudkorsnas.com/investors/financial-reports, and is attached to this press release. For more information, please contact:Lena Schattauer, Director Investor Relations, +46 8 553 335 10Andreas Drugge, Sustainability Manager, +46 8 553 336 43This information is information that BillerudKorsnäs AB is obliged to make public pursuant to the Securities Market Act. The information was submitted for

Conference call interim report

Invitation to attend Vitrolife’s conference call regarding presentation of the interim report January – March 2022. The presentation will be held in English.Time: Friday 22 April, 2022 at 10.00 a.m. CET.Registration can preferably be done 10-15 minutes before the conference start time on: Sweden dial in number: +46 (0)8 506 921 69International dial in number: +44 (0) 2030 095709Conference name: Vitrolife, conference ID: 6938009Event Passcode: 6938009 Vitrolife participants:Thomas Axelsson, CEOPatrik Tolf, CFOThe press release for Vitrolife’s interim report will be

DOF Subsea awarded multiple contracts for the Ross Candies

DOF Subsea USA is pleased to announce the award of multiple contracts for the Ross Candies. The vessel will be utilised well into Q3 2022, undertaking jumper installations, span remediation, pre-commissioning, decommissioning, pipelay support and IMR activities at multiple field locations in the Gulf of Mexico. For further information, please contact: Mons S. Aase, CEO Tel: +47 91 66 10 12 Hilde Drønen, CFO Tel.: +47 91 66 10 09

Invitation to Kesko’s Q1 interim report briefing on 29 April 2022

A stock exchange release concerning Kesko's financial statements for January-March 2022 will be published on Friday, 29 April 2022, at around 8.00 am (EET/EEST).A teleconference in English will be held at 9.00 am (EET/EEST). It will include a presentation by the President and CEO Mikko Helander, after which the whole Group Management Board will be available for questions. A link to the teleconference is available at www.kesko.fi/report-centre.  Registration is required for the teleconference. A recording of the event

2020 Bulkers Ltd. (2020) – Grant of share options

Hamilton, Bermuda, April 8, 2022 In January 2019, the Board of Directors established a long-term incentive plan and approved a grant of 740,000 share options to employees and directors (the “LTI Plan”). The Board has resolved to grant 60,000 share options to employees including one person discharging managerial responsibilities (“PDMR”) as defined by the Market Abuse Regulation pursuant to the Company's LTI Plan. Each share option gives the holder the right to purchase one share in the Company at an exercise price of US$18 per share. The share options will vest equally over a three

Notice to attend the annual general meeting of SyntheticMR AB (publ)

The shareholders of SyntheticMR AB (publ), corporate Reg. No. 556723-8877, are hereby invited to attend the annual general meeting on Tuesday 10 May 2022, at 18:00 CET at the company's premises on Storgatan 11 in Linköping.Right to attend the general meeting Shareholders who wish to attend the general meeting must: · be registered as a shareholder in share register maintained by Euroclear Sweden AB on the record date, Monday 2 May 2022, and · no later than Wednesday 4 May 2022 at 16:00 CET notify the company of its and any assistants' (no more than two) intention to attend the

Getinge announces its Q1 Report 2022 on April 26 at 08:00 CEST followed by a conference call at 10:00 CEST

Getinge will issue its Q1 Report 2022 on April 26, 2022, at 08:00 CEST, followed by a conference call at 10:00 CEST, hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO.Fund managers, analysts and media are invited to participate in the conference call. Please see dial in details below to join the conference: SE: +46 8 505 583 66UK: +44 333 300 92 71US: +1 631 913 14 22 During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/getinge-q1-2022 Alternatively, use the

There are no items matching the current filter
There are no more items matching the current filter
Back to top